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Abstract
Introduction:  Since  the  introduction  of  nasal  endoscopy  into  the  field  of  Otorhinolaryngology,
the treatment  paradigm  for  cases  of  severe  epistaxis  has  shifted  toward  early  and  precise
identification  of  the  bleeding  site.  Although  severe  epistaxis  is  usually  considered  to  arise  from
posterior  bleeding,  an  arterial  vascular  pedicle  in  the  superior  portion  of  the  nasal  septum,
around the  axilla  projection  of  the  middle  turbinate,  posterior  to  the  septal  body,  frequently
has been  observed.  That  vascular  pedicle  was  named  the  Stamm’s  S-point.
Objective:  The  aim  of  this  study  was  to  describe  the  S-point  and  report  cases  of  severe  epistaxis
originating  from  it.
Methods:  A  retrospective  case  series  study  was  conducted.  Nine  patients  with  spontaneous
severe epistaxis,  where  the  S-point  was  identified  as  the  source  of  bleeding,  were  treated
between March  2016  and  March  2017.
Results:  Male  predominance  (77.8%)  with  age  average  of  59.3  years  old  were  reported.  Most
cases presented  comorbidities  (88.9%)  and  were  not  taking  acetylsalicylic  acid  (66.7%).  A  pre-
dominance  of  left  sided  involvement  (55.6%)  and  anteroposterior  bleeding  being  the  principal
initial presentation  (77.8%)  was  seen.  Six  patients  (66.7%)  presented  with  hemoglobin  levels
below 10  g/dL,  and  four  (44.4%)  required  blood  transfusion.  Cauterization  of  S-point  was  per-
formed in  all  patients,  with  complete  resolution  of  bleeding.  No  patient  experienced  recurrence
of severe  epistaxis. Please cite this article as: Kosugi EM, Balsalobre L, Mangussi-Gomes J, Tepedino MS, San-da-Silva DM, Cabernite EM, et al. Breaking
aradigms in severe epistaxis: the importance of looking for the S-point. Braz J Otorhinolaryngol. 2018;84:290--7.
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Conclusion:  The  Stamm’s  S-point,  a  novel  source  of  spontaneous  severe  epistaxis,  is  reported,
and its  cauterization  was  effective  and  safe.  Otolaryngologists  must  actively  seek  this  site  of
bleeding in  cases  of  severe  epistaxis.
© 2018  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published
by Elsevier  Editora  Ltda.  This  is  an  open  access  article  under  the  CC  BY  license  (http://
creativecommons.org/licenses/by/4.0/).
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Quebrando  paradigmas  na  epistaxe  grave:  a importância  de  procurar  o  S-point
Resumo
Introduc¸ão:  Desde  a  introduc¸ão  da  endoscopia  nasal  no  campo  de  Otorrinolaringologia,  o
paradigma  de  tratamento  para  casos  graves  de  epistaxe  voltou-se  para  a  identificac¸ão  pre-
coce e  correta  do  local  de  sangramento.  Embora  a  epistaxe  grave  seja  geralmente  considerada
uma hemorragia  posterior,  um  pedículo  vascular  arterial  tem  sido  frequentemente  observado
na porc¸ão  superior  do  septo  nasal,  ao  redor  da  projec¸ão  da  axila  da  concha  média,  posterior
ao tubérculo  septal.  Esse  pedículo  vascular  foi  chamado  de  Stamm’s  S-point.
Objetivo:  O  objetivo  deste  estudo  foi  descrever  o  S-point  e  relatar  casos  graves  de  epistaxe
originando-se  neste  local.
Método:  Um  estudo  retrospectivo  de  série  de  casos  foi  conduzido.  Nove  pacientes  com  epistaxe
grave espontânea,  onde  o  S-point  foi  identificado  como  a  fonte  do  sangramento,  foram  tratados
no período  de  marc¸o  de  2016  a  marc¸o de  2017.
Resultados:  Houve  predominância  do  sexo  masculino  (77,8%)  com  idade  média  de  59,3  anos.
A maioria  dos  casos  apresentava  comorbidades  (88,9%),  mas  sem  uso  de  ácido  acetilsalicílico
(66,7%).  Observou-se  predominância  do  lado  esquerdo  (55,6%)  com  sangramento  anteroposte-
rior como  a  principal  apresentac¸ão  inicial  (77,8%).  Seis  pacientes  (66,7%)  apresentaram  níveis
de hemoglobina  inferiores  a  10  g/dL  e  quatro  (44,4%)  necessitaram  de  transfusão  sanguínea.
Cauterizac¸ão do  S-point  foi  realizada  em  todos  os  pacientes,  com  resoluc¸ão  completa  do  san-
gramento. Nenhum  paciente  apresentou  recorrência  de  epistaxe  grave.
Conclusão:  O  Stamm’s  S-point  é  relatado  como  uma  nova  região  de  origem  de  epistaxe  grave
espontânea,  e  o  tratamento  realizado  com  cauterizac¸ão  foi  eficaz  e  seguro.  Os  otorrinolaringol-
ogistas  devem  buscar  ativamente  este  local  de  sangramento  em  casos  de  epistaxe  grave.
© 2018  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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Epistaxis  is  one  of  the  most  common  emergencies  in  oto-
rhinolaryngology  practice.1 It  is  extremely  common  in  the
general  population;  however,  it  is  estimated  that  only  10%  of
affected  individuals  seek  medical  care,  because  it  is  usually
benign  and  self-limited.2--4 Severe  epistaxis,  that  is  poten-
tially  life-threatening  and  requires  immediate  and  urgent
treatment,5 is  less  common,  but  its  occurrence  in  special-
ized  Otorhinolaryngology  services  can  comprise  up  to  4%  of
the  cases.1
Severe  epistaxis  is  traditionally  thought  to  arise  from
posterior  bleeding,5 although  the  site  of  origen  is  not
adequately  identified  in  up  to  50%  of  severe  or  recur-
rent  cases.5,6 Therefore,  the  usual  surgical  treatment  of
severe  epistaxis  involves  cauterization  of  branches  of  the
sphenopalatine  artery,  and  has  a  high  rate  of  success,  but
sometimes  there  is  a  need  for  an  approach  involving  the
anterior  ethmoidal  artery  (AEA).5,7
The  superior  portion  of  the  nasal  septum  has  been  con-
sidered  an  important  site  of  severe  epistaxis,  especially  the
f
t
bEA  branches  (Fig.  1).8 More  specifically,  a bleeding  point
as  been  described  by  the  senior  author  (ACS)  in  the  upper
asal  septum,  around  the  ‘‘axilla’’  projection  of  the  middle
urbinate,  posterior  to  the  septal  body,  that  presents  as  an
rterial  vascular  pedicle,  usually  with  active  bleeding  (anec-
otal  reference).  This  arterial  vascular  pedicle  was  named
tamm’s  S-point  (Fig.  2).
Currently,  the  S-point  appears  to  be  a  frequent  cause
f  severe  epistaxis.  Due  to  its  arterial  nature,  the  S-point
leeding  may  be  forceful  enough  to  reach  the  lateral  nasal
all  and  flow  posteriorly,  being  mistakenly  identified  as
osterior  epistaxis  (Fig.  2).  Furthermore,  the  S-point  area,
uch  superior,  located  around  the  axilla  of  the  middle
urbinate,  is  not  an  area  routinely  examined  by  the  otorhi-
olaryngologist  during  nasal  endoscopic  surgeries,  and  may
e  difficult  to  access  endoscopically,  since  it  is  posterior
o  the  septal  body.  Therefore,  severe  epistaxis  originating
rom  the  S-point  may  not  be  diagnosed  correctly,  leading  to
herapeutic  failures.
This  report  is  the  first  to  describe  this  specific  point  of
leeding  in  severe  epistaxis.  The  aim  of  this  study  is  to  report
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Figure  1  Microscopic  cauterization  of  the  branches  of  the
anterior ethmoidal  artery  (AEA,  anterior  ethmoidal  artery;  PEA,
posterior  ethmoidal  artery;  S,  septum).
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Figure  2  Left  nasal  cavity,  upper  endoscopic  view,  above  the
axilla of  the  middle  turbinate  (A).  The  S-point  (black  arrow)
is a  vascular  pedicle  in  the  upper  portion  of  the  nasal  septum
(S). Note  that  the  blood  pulsation  can  be  strong  enough  to  reach
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(11.1%)  had  no  comorbidities,  and  3  (33.3%)  used  ASA  dailyhe lateral  nasal  wall,  with  a  posterior  flow,  simulating  posterior
pistaxis  (MT,  middle  turbinate).
ine  patients  in  which  the  S-point  was  the  source  of  severe
pistaxis.
ethod
his  is  a  series  of  cases  of  patients  who  experienced  episodes
f  severe  epistaxis  between  March  2016  and  March  2017  in
hree  different  hospitals  (São  Paulo  Hospital,  Edmundo  Vas-
oncelos  Hospital,  and  Botafogo  Polyclinic),  in  which  the
-point  was  identified  as  the  source  of  the  bleeding.
d
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pKosugi  EM  et  al.
The  study  was  approved  by  the  Research  Ethics  Commit-
ee  (n.  1890166)  and  the  participants  signed  the  free  and
nformed  consent  form.
nclusion  criteria
Severe  epistaxis  with  S-point  origin;
Treatment  with  S-point  cauterization;
Volunteers  to  participate  in  the  study.
xclusion  criteria
Severe  epistaxis  with  sources  other  than  the  S-point;
Severe  epistaxis  of  unknown  origin;
Concomitant  treatment  with  sphenopalatine  artery  cauter-
ization;
Concomitant  treatment  with  anterior  ethmoidal  artery
cauterization.
The  following  data  were  collected:  age,  gender,  presence
f  comorbidities,  use  of  acetylsalicylic  acid  (ASA),  epistaxis
aterality,  anterior  and/or  posterior  presentation  of  bleed-
ng,  initial  treatment  performed,  hemoglobin  levels  (Hb),
resence  of  coagulation  disorders,  need  for  blood  transfu-
ion,  surgical  treatment  performed  and  time  of  follow-up.
dentification  of  the  S-point
or  the  correct  identification  of  the  origin  of  the  severe  epis-
axis,  the  entire  nasal  cavity  was  carefully  examined  with  a
ero-degree  endoscope,  especially  the  superior  portion  of
he  nasal  septum  around  the  middle-turbinate  axilla  pro-
ection,  posterior  to  the  septal  body,  where  the  S-point  is
sually  found  (Fig.  3,  Supplemental  Material  --  video  1).
or  that  purpose,  the  endoscope  had  to  be  directed  to  the
pper  region  of  the  nasal  cavity,  above  the  middle  mea-
us,  in  an  area  not  usually  accessed  during  traditional  nasal
ndoscopic  surgeries.
In  some  cases,  a  slight  compression  of  the  septal  body
sing  a  Cottle  elevator,  or  even  septoplasty,  was  necessary
or  proper  visualization  of  the  S-point.
Two  other  measures  were  necessary  to  identify  the
-point  at  the  initial  endoscopic  evaluation:  blood  pres-
ure  levels  needed  to  be  normal,  without  hypotension;
nd  decongestant  solutions  could  not  be  used  until  com-
lete  nasal  endoscopic  nasal  evaluation.  The  use  of  cotton
ledgets  soaked  in  decongestant  solutions  could  promote
asoconstriction  of  the  arterial  pedicle  and  temporary
emostasis,  making  the  S-point  identification  impossible
Fig.  4, Supplemental  Material  --  video  2).
esults
ine  patients  who  met  all  the  inclusion  and  exclusion  crite-
ia  were  identified:  7  men  (77.8%),  with  a  mean  age  of
9.3  years  (median  58  years,  34--88  years).  Only  one  patientue  to  coronary  artery  disease.  Five  patients  (55.6%)  bled
rom  the  left  nasal  cavity  (LNC),  with  the  anteroposterior
resentation  being  the  most  common  (7  patients,  77.8%).
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Figure  3  Left  nasal  cavity,  anatomical  dissection  (1)  and  endoscopic  view  (2).  The  black  circle  and  the  yellow  area  show  the
region where  the  S-point  (a  branch  of  the  anterior  ethmoidal  artery)  can  be  found,  superior  to  the  middle  meatus,  in  a  region  that  is
normally not  assessed  in  nasal  endoscopic  surgeries  (Ant,  anterior;  Pos,  posterior;  AEA,  anterior  ethmoidal  artery;  NSA,  nasoseptal
artery; SS,  sphenoidal  sinus;  S,  nasal  septum;  A,  middle  turbinate  axilla;  MT,  middle  turbinate).
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Figure  4  Right  nasal  cavity.  S-point  (yellow  circle)  before  (1)  and  after  (2)  the  use  of  cotton  pledgets  with  topical  decongestant.
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aAfter vasoconstriction,  the  S-point  vascular  pedicle  practically  
S, nasal  septum).
Anterior  nasal  packing  was  the  main  initial  treatment  (5
patients,  55.6%).  Six  patients  (66.7%)  had  Hb  levels  lower
than  10  g/dL,  and  4  (44.4%)  required  a  blood  transfusion.
Only  one  patient  (11.1%)  had  coagulation  disorders.  All
patients  underwent  cauterization  of  the  S-point,  without
manipulation  of  the  sphenopalatine  and/or  ethmoidal  arter-
ies.  There  was  no  recurrence  of  bleeding  during  the  mean
postoperative  period  of  10  months  (median:  11  months,  2--18
months).  The  data  are  shown  in  Table  1.
Case  presentation
1st  Patient:  58-year-old  male,  hypertensive  patient,  receiv-
ing  atenolol  and  hydrochlorothiazide,  with  a  history  of
severe  epistaxis  in  LNC,  was  submitted  to  cauterization  of
the  ipsilateral  sphenopalatine  and  anterior  ethmoidal  arter-
ies  9  months  before,  with  surgical  revision  one  month  after
the  procedures  due  bleeding  recurrence.  He  had  no  bleed-
ing  episodes  for  8  months,  when  he  had  a  new  episode  of
a
E
c
dpears  (A,  axilla  of  the  middle  turbinate;  MT,  middle  turbinate;
evere  epistaxis  in  the  LNC,  controlled  by  anterior  nasal
acking.  A  nasal  endoscopy  was  performed  under  general
nesthesia  and  active  bleeding  of  the  S-point  was  identified
Fig.  5(1)),  which  ceased  after  electrical  cauterization.  The
atient  has  remained  without  bleeding  episodes  during  the
-month  postoperative  period.
2nd  Patient:  53-year-old  male  patient  with  chronic
epatitis  B  infection  was  on  the  waiting  list  for  liver  trans-
lantation,  experienced  severe  epistaxis  in  the  LNC  with
igns  of  hypovolemic  shock.  He  was  underwent  hemody-
amic  stabilization  with  3  L  of  lactated  Ringer’s  solution  and
nteroposterior  nasal  packing  with  control  of  the  bleeding.
is  hemoglobin  levels  decreased  from  9.0  to  7.8  g/dL,  with
n  INR  of  2.12.  After  transfusion  of  two  units  of  packed  red
lood  cells  and  three  units  of  platelets,  the  nasal  cavity  was
ssessed  with  a  rigid  endoscope  under  general  anesthesia
nd  active  bleeding  of  the  S-point  was  identified  (Fig.  5(2)).
lectrical  cauterization  of  the  S-point  was  performed,  with
ontrol  of  the  bleeding.  The  patient  has  remained  stable
uring  the  postoperative  period  of  5  months.
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Table  1  Patients’  characteristics  --  S-point  severe  epistaxis.
Patient  Age  GenderComorbities  ASA  user  Side  Anterior
bleeding
Posterior
bleeding
Initial  treatment  Hematological
repercussion
Coagulation
disorders
Blood
transfusion
Follow-up
period
Final
treatment
1  58  M  SAH  No  Left  Yes  Yes  Anterior  Packing  Hb  11.9  No  No  8  mo  S-point
Cauterization
2 53  M  Hepatitis  B  No  Left  Yes  Yes  Anteroposterior
Packing
Hb  7.8  Yes  2  units  5  mo  S-point
Cauterization
3 34  M  No  No  Right  Yes  Yes  Anterior  Packing  Hb  7.2  No  No  12  mo  S-point
Cauterization
4 63  M  Malnutrition,  SAH  No  Right  Yes  Yes  Anterior  Packing  Hb  6.2  No  2  units  18  mo  S-point
Cauterization
5 71  M  SAH,  MR  Yes  Right  Yes  Yes  Anterior  Packing  Hb  8.0  No  2  units  18  mo  S-point
Cauterization
6 58  F  SAH,  Rheumatoid
arthritis
No  Left  Yes  No  No  Hb  8.1  No  2  units  11  mo  S-point
Caut.
Septoplasty
7 71  M  SAH,  MR,  DM  Yes  Right  Yes  Yes  Anterior  Packing  Hb  12.1  No  No  14  mo  S-point
Cauterization
8 88  M  SAH,  MR,  DM
Psoriatic  arthritis
Yes  Left  Yes  No  No  Hb  11.7  No  No  2  mo  S-point
Cauterization
9 38  F  SAH  No  Left  Yes  Yes  Anteroposterior
Packing
Hb  9.2  No  No  2  mo  S-point
Cauterization
ASA, acetylsalicylic acid; M, male; F, female; SAH, systemic arterial hypertension; MR, myocardial revascularization; DM, diabetes mellitus; Hb, hemoglobin.
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lFigure  5  Identification  of  the  S-point  in  nine  cases  (1--9).  Th
axilla of  the  middle  turbinate;  MT,  middle  turbinate).
3rd  Patient:  34-year-old  male  patient  had  recurrent  epis-
taxis  in  the  Right  Nasal  Cavity  (RNC)  for  3  days.  The  bleeding
was  spontaneous,  voluminous,  but  self-limited.  During  medi-
cal  care,  he  had  mild  bleeding  in  the  RNC,  controlled  with
anterior  nasal  packing.  Due  to  the  recurrence  of  the  condi-
tion  and  the  presence  of  a  serum  hemoglobin  level  of
7.2  g/dL,  endoscopic  examination  under  general  anesthesia
was  performed,  which  revealed  mild  active  bleeding  from  S-
point  (Fig.  5(3)).  The  bleeding  was  controlled  by  electrical
cauterization  and  the  patient  has  not  had  any  recurrences
during  one  year  of  follow-up.
4th  Patient:  63-year-old  male  patient  with  malnutrition
and  poorly-controlled  systemic  arterial  hypertension  (SAH)
presented  recurrent  episodes  of  severe  epistaxis  in  RNC  in
the  previous  2  days.  During  the  physical  examination,  he  had
severe  nasal  bleeding,  controlled  by  bilateral  anterior  nasal
packing.  There  was  a  decrease  in  hemoglobin  levels  on  these
2  days,  from  10.7  to  6.2  g/dL,  requiring  the  transfusion  of
r
m
bpoint  was  identified  with  a  yellow  circle  (S,  nasal  septum;  A,
wo  units  of  packed  red  blood  cells.  The  patient  was  taken  to
he  OR  for  nasal  endoscopy,  which  identified  active  bleed-
ng  from  the  S-point  on  the  right  (Fig.  5(4),  Supplemental
aterial  --  video  3),  adequately  controlled  by  electrical  cau-
erization.  There  have  been  no  recurrences  during  the  18
ostoperative  months.
5th  Patient:  71-year-old,  male,  well-controlled  hyperten-
ive  patient,  with  a  history  of  myocardial  revascularization
nd  daily  use  of  ASA.  He  had  already  been  successfully  sub-
itted  to  electrical  cauterization  of  the  S-point  in  LNC  2
onths  before,  and  now  had  severe  epistaxis  lasting  one
ay  in  the  RNC;  it  was  not  possible  to  identify  the  bleed-
ng  point  at  the  emergency  evaluation;  the  hemorrhage  was
ontrolled  with  anterior  nasal  packing.  He  had  a  hemoglobin
evel  of  8.0  g/dL,  with  symptoms  of  acute  anemia,  so  he
eceived  two  units  of  packed  red  blood  cells  and  was  sub-
itted  to  nasal  endoscopy  under  general  anesthesia.  Active
leeding  of  the  S-point  in  RNC  was  located  (Fig.  5(5))  and
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uccessfully  cauterized,  and  the  patient  has  not  had  new
leeding  episodes  for  18  months  postoperatively.
6th  Patient:  58-year-old  female  patient,  with  uncon-
rolled  hypertension  and  rheumatoid  arthritis,  using
ydroxychloroquine,  had  had  intermittent  and  severe,  but
elf-limited  epistaxis  in  LNC  during  the  past  three  months.
fter  a  new  episode  of  severe  epistaxis,  the  patient  was
dmitted  without  active  bleeding.  She  had  a  previous
emoglobin  level  of  12.5  g/dL,  which  decreased  to  8.1  g/dL
t  admission,  requiring  the  transfusion  of  two  units  of
acked  red  blood  cells.  Under  general  anesthesia,  nasal
ndoscopic  exploration  showed  the  S-point  in  LNC  with  signs
f  recent  bleeding  (Fig.  5(6)).  Septoplasty  was  performed  to
acilitate  access  and  electrical  cauterization  of  the  S-point.
he  has  had  no  recurrences  in  the  11  months  of  follow-up.
7th  Patient:  71-year-old  male  patient,  with  well-
ontrolled  hypertension  and  type  2  diabetes,  previous
yocardial  revascularization  and  daily  use  of  ASA,  was
dmitted  with  active  severe  epistaxis  in  RNC.  The  patient
ad  longstanding  recurrent  epistaxis,  which  had  worsened  in
he  5-day  period  prior  to  admission.  The  bleeding  was  con-
rolled  with  anterior  nasal  packing.  He  had  a  hemoglobin
evel  of  12.1  g/dL.  Nasal  endoscopy  was  performed  under
eneral  anesthesia  and  active  bleeding  of  the  S-point  on  the
ight  was  identified  (Fig.  5(7)).  The  bleeding  was  controlled
ith  electrical  cauterization  of  the  S-point  and  the  patient
as  remained  stable  for  14  months  of  follow-up.
8th  Patient:  88-year-old  male  patient,  with  controlled
AH,  type  2  diabetes  and  psoriatic  arthritis,  and  a  history  of
oronary  angioplasty  20  years  before,  in  addition  to  daily
se  of  ASA.  He  had  episodes  of  severe,  intermittent  and
elf-limited  epistaxis  in  the  LNC  in  the  last  two  months,
ccasionally  associated  with  hypertensive  peaks.  He  was
valuated  in  the  absence  of  a  bleeding  episode  and  nasal
ndoscopy  was  performed,  which  showed  S-point  on  the
eft.  His  hemoglobin  level  was  11.7  g/dL,  without  coagula-
ion  disorders.  He  was  admitted  to  undergo  nasal  endoscopy
nder  general  anesthesia,  which  confirmed  the  presence  of
he  S-point  (Fig.  5(8)),  without  active  bleeding  at  the  time
f  evaluation;  the  S-point  was  electrically  cauterized.  The
atient  has  remained  stable  for  2  months  of  follow-up.
9th  Patient:  38-year-old  female,  hypertensive  patient,
sing  five  antihypertensive  drugs.  She  had  had  frequent,
ntermittent,  but  self-limited  bouts  of  epistaxis  in  LNC  in  the
ast  4  months.  She  was  admitted  with  high-intensity  epistaxis
n  LNC,  and  anteroposterior  nasal  packing  was  required  to
ontrol  the  condition.  Nasal  endoscopic  examination  under
eneral  anesthesia  identified  the  S-point  with  active  bleed-
ng  in  LNC  (Fig.  5(9)).  The  admission  hemoglobin  level  was
.2  g/dL,  without  coagulation  disorders,  and  there  was  no
eed  for  blood  transfusion.  Successful  electrical  cauteriza-
ion  was  performed,  and  there  has  been  no  recurrence  for
 months  postoperatively.
iscussion
he  surgical  treatment  of  severe  epistaxis  has  evolved
rom  heroic  measures,  such  as  external  carotid  artery  liga-
ion,  to  procedures  that  increasingly  value  the  accurate
dentification  and  control  of  the  bleeding  point.  Sphenopala-
ine  artery  endoscopic  cauterization  is  currently  the  most
C
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ommonly  performed  surgical  procedure  for  severe  epis-
axis,  and  the  use  of  endoscopes  has  allowed  the  surgical
echnique  refinement  to  increase  procedural  efficacy.5,9 The
opularization  of  nasal  endoscopy  has  encouraged  the  active
earch  for  the  bleeding  point,  previously  restricted  to  the
iesselbach’s  plexus,  now  with  the  possibility  of  identify-
ng  posterior  bleeding  points  in  the  nasal  cavity.  Therefore,
asal  endoscopy  has  resulted  in  an  important  change  in
aradigm  regarding  the  treatment  of  severe  epistaxis.6
There  is  much  controversy  about  the  location  of  severe
leeding  cases,  perhaps  due  to  the  lack  of  standardization
n  their  search.10 Thornton  et  al.  (2005)11 identified  the  lat-
ral  nasal  wall  as  the  main  site  of  bleeding,  with  the  upper
asal  septum  accounting  for  only  16.3%  of  the  cases.  Almeida
t  al.  (2005)6 identified  the  nasal  septum  as  the  main  site  of
evere  posterior  bleeding  (46.6%);  however,  their  study  only
dentified  an  anterior  or  posterior  location  of  bleeding,  and
id  not  report  whether  the  bleeding  was  superior.  Finally,
hiu  and  McGarry  (2007)10 also  reported  that  most  cases  of
osterior  epistaxis  originated  from  the  nasal  septum,  equally
istributed  between  the  upper  and  lower  portions.  One  fac-
or  is  crucial:  without  using  the  endoscope,  the  bleeding
oint  might  not  be  located  in  half  of  the  cases.5
Although  these  previous  studies  confirmed  the  nasal  sep-
um  as  a frequent  source  of  severe  epistaxis,  a  specific
nd  constant  site  of  septal  bleeding  was  not  identified.
he  present  study  described  an  identifiable,  stable  source
f  bleeding  in  patients  with  severe  epistaxis,  located  in
he  upper  nasal  septum,  around  the  middle  turbinate  axilla
rojection,  posterior  to  the  septal  body.  Although  it  is
ot  possible  to  determine  prevalence  rates  with  this  study
esign,  the  S-point  seems  to  be  a  frequent  cause  of  bleeding
n  severe  epistaxis.
Currently,  the  bleeding  point  identification  and  subse-
uent  cauterization  is  considered  an  adequate,  effective
nd  safe  approach  in  the  management  of  severe  epis-
axis,  being  less  invasive  than  the  sphenopalatine  artery
auterization.6 The  present  study  characterized  for  the  first
ime  the  S-point,  a  stable  point  of  severe  epistaxis,  in  a  site
ot  usually  evaluated  during  nasal  endoscopic  examination.
t  has  also  been  shown  that,  when  identified,  S-point  cauter-
zation  was  an  effective  and  safe  method  for  the  treatment
f  severe  epistaxis,  even  in  patients  with  comorbidities
nd  coagulation  disorders.  Therefore,  the  active  search  and
dentification  of  the  S-point  as  the  origin  of  bleeding  can
hange  the  paradigm  in  the  management  of  patients  with
evere  epistaxis,  and  lead  to  a  simpler  and  more  effective
pproach.
onclusion
he  Stamm’s  S-point  was  reported  as  the  source  of  bleeding
n  severe  epistaxis.  Nine  cases  of  S-point  severe  epistaxis
ffectively  treated  only  by  S-point  electrical  cauterization
ere  reported.  The  dissemination  of  S-point  knowledge  as  a
ause  of  severe  bleeding  may  increase  the  success  of  surgical
reatment  of  epistaxis  and  decrease  its  morbidity.onflicts of  interest
he  authors  declare  no  conflicts  of  interest.
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1Breaking  paradigms  in  severe  epistaxis:  the  importance  of  lo
Appendix A. Supplementary data
Supplementary  data  associated  with  this  arti-
cle  can  be  found,  in  the  online  version,  at
doi:10.1016/j.bjorl.2017.12.007.
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